Managing myelodysplastic symptoms in elderly patients
Most patients with myelodysplastic syndromes (MDS) are elderly (median age range 65 to
70 years); as a consequence, the incidence and prevalence of these diseases are rising as …
70 years); as a consequence, the incidence and prevalence of these diseases are rising as …
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
K Götze, U Platzbecker, A Giagounidis, D Haase… - Annals of …, 2010 - Springer
Myelodysplastic syndromes (MDS) are a group of common bone marrow disorders
characterized by ineffective hematopoiesis, peripheral cytopenias, and a substantial risk of …
characterized by ineffective hematopoiesis, peripheral cytopenias, and a substantial risk of …
Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic …
E Verburgh, R Achten, B Maes… - Journal of clinical …, 2003 - ascopubs.org
Purpose: The most recent and powerful prognostic instrument established for
myelodysplastic syndromes (MDS) is the International Prognostic Scoring System (IPSS) …
myelodysplastic syndromes (MDS) is the International Prognostic Scoring System (IPSS) …
The evolution of hematopoietic SCT in myelodysplastic syndrome
T Kindwall-Keller, LM Isola - Bone marrow transplantation, 2009 - nature.com
Allogeneic hematopoietic SCT (allo-HCT) is the only curative therapy for myelodysplastic
syndrome (MDS). Numerous myeloablative (MA), nonmyeloablative SCT (NST) and reduced …
syndrome (MDS). Numerous myeloablative (MA), nonmyeloablative SCT (NST) and reduced …
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated …
M Jurado, HJ Deeg, B Storer, C Anasetti… - Biology of blood and …, 2002 - tctjournal.org
The objectives of this study were to develop transplantation regimens for patients with
advanced myelodysplastic syndrome (MDS) that would be associated with low …
advanced myelodysplastic syndrome (MDS) that would be associated with low …
Hematopoietic cell transplantation (HCT) in MDS patients of older age
C Niederwieser, N Kröger - Leukemia & Lymphoma, 2024 - Taylor & Francis
Hematopoietic cell transplantation (HCT) has evolved to an essential treatment in younger
and more recently in elderly patients with myelodysplastic syndrome (MDS), the age group …
and more recently in elderly patients with myelodysplastic syndrome (MDS), the age group …
Myelodysplastic syndromes.
WK Hofmann, M Lübbert, D Hoelzer… - The Hematology Journal …, 2004 - europepmc.org
Myelodysplastic syndrome (MDS) is a clonal disorder characterized by ineffective
hematopoiesis, which can lead to either fatal cytopenias or acute myelogenous leukemias …
hematopoiesis, which can lead to either fatal cytopenias or acute myelogenous leukemias …
[HTML][HTML] Infections in myelodysplastic syndrome in relation to stage and therapy
Infections remain a significant problem in myelodysplastic syndromes (MDS) in treated as
well in non-treated patients and assume a particular complexity. The susceptibility to …
well in non-treated patients and assume a particular complexity. The susceptibility to …
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
M Robin, GF Sanz, I Ionescu, B Rio, A Sirvent… - Leukemia, 2011 - nature.com
The aim of our study was to evaluate, through the Eurocord and European Group for Blood
and Marrow Transplantation (EBMT) registries, outcomes and risk factors for outcomes in …
and Marrow Transplantation (EBMT) registries, outcomes and risk factors for outcomes in …
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid …
WK Hofmann, G Heil, C Zander, S Wiebe… - Annals of …, 2004 - Springer
In an attempt to improve the complete remission (CR) rates and to prolong the remission
duration especially in elderly patients> 50 years of age, we have used a combination …
duration especially in elderly patients> 50 years of age, we have used a combination …